Lillian Skidmore

Lillian Skidmore is a highly experienced individual with a background in Human Nutrition/Biochemistry and Neurobiology & Behavior. Currently serving as the Senior Director of Translational Sciences at Ambrx, Lillian has been instrumental in leading projects and teams, resulting in the selection of a candidate for clinical development. Formerly a Research Associate V at Regeneron Pharmaceuticals, Lillian played a crucial role in the development of the "VEGF Trap" therapeutic, approved for use in wet AMD patients and metastatic colorectal cancer patients.